Opioid Quantity Limit Overrides

Indications for Prior Authorization

Criteria

Authorization will be issued for long-term therapy. *For oral fentanyl products, please refer to the drug-specific quantity limit override criteria in the “Oral Fentanyl Products” guideline.

Administrative

Length of Approval: 5 Year(s)
For diagnosis of For Malignant Cancer Pain

  • In the absence of an opioid-specific quantity limit override guideline, the following approval criteria will be used:
    • Diagnosis of malignant (cancer) pain*

Administrative

Length of Approval: 1 Year(s)
For diagnosis of For Non-Malignant Pain

  • In the absence of an opioid-specific quantity limit override guideline, the following approval criteria will be used:
    • Prescribed by a pain specialist or by pain management consultation
    • AND
    • The prescriber maintains and provides chart documentation of the patient’s evaluation, including all of the following:
      • An appropriate patient medical history and physical examination
      • A description of the nature and intensity of the pain
      • Documentation of appropriate dose escalation
      • Documentation of ongoing, periodic review of the course of opioid therapy
      • An updated, comprehensive treatment plan (the treatment plan should state objectives that will be used to determine treatment success, such as pain relief or improved physical and/or psychosocial function)
      • Verification that the risks and benefits of the use of the controlled substance have been discussed with the patient, significant other(s), and/or guardian
P & T Revisions

2024-11-06, 2023-10-19, 2022-10-19, 2022-01-14, 2021-10-28, 2021-09-28, 2021-05-21, 2020-10-29, 2019-10-29


  • 2024-11-06: 2024 Annual Review. No criteria changes.
  • 2023-10-19: Annual review
  • 2022-10-19: Annual review
  • 2022-01-14: Annual Review
  • 2021-10-28: Annual Review
  • 2021-09-28: Addition of EHB formulary to guideline, no changes to criteria
  • 2021-05-21: Addition of EHB formulary to guideline, no changes to criteria
  • 2020-10-29: UM annual review.
  • 2019-10-29: 2019 Annual Review

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone